SRTA today
$6.01-$0.01 (-0.17%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bearish
Daily trend turns down below $3.95
Key levels
Resistance$6.86
Resistance$6.33
Support$5.97
Support$5.52
Latest news & SEC filings
EarningsStrata Critical Medical reports third quarter 2026 results
EarningsStrata Critical Medical holds Q3 2026 earnings call
EarningsStrata Critical Medical posts wider quarterly loss, revenue tops forecast
All SRTA news →About Strata Critical Medical
Strata Critical Medical serves the American healthcare sector with urgent transport and medical offerings centered on organ transplants. Its logistics arm arranges airplane and vehicle movement of organs, related personnel, samples and equipment, plus administrative help matching donated organs with recipients. Its clinical arm supplies surgical procurement, perfusion, preservation and cardiac care staffing to transplant programs, organ procurement groups and hospitals.
Based on the company's 10-K filed Mar 3, 2026.
Nasdaq · Industrials
Strata Critical Medical, Inc. (SRTA)
What Is the Price Target for SRTA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is SRTA a Buy or Sell Right Now?
Thesis
- •Revenue growing 34.3% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SRTA.
Start Free Trial →Is SRTA Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, PEG
Fair Value
$3.62
50
Moat Score
NARROW
4/9
Piotroski Score
4.9
Altman Z-Score
What Is Smart Money Doing with SRTA?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wunsch Scott M | officer | Buy | 57,173 | - | Oct 28, 2026 |
| Wunsch Scott M | officer | Buy | 1,416 | - | Oct 28, 2026 |
| Wunsch Scott M | officer | Sale | 44,996 | $214K | Oct 28, 2026 |
| Tomkiel Melissa M. | director officer | Buy | 177,858 | - | Sep 24, 2026 |
| Tomkiel Melissa M. | director officer | Sale | 90,797 | $479K | Sep 24, 2026 |
| Heyburn William A. | director officer | Buy | 177,858 | - | Sep 24, 2026 |
| Heyburn William A. | director officer | Sale | 98,356 | $518K | Sep 24, 2026 |
| Verdetto Louis R. | officer | Sale | 5,697 | $30K | Sep 8, 2026 |
| Wunsch Scott M | officer | Sale | 5,711 | $30K | Sep 8, 2026 |
| Cohen Amir | officer | Sale | 4,645 | $25K | Sep 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SRTA Growth Story
Revenue YoY
34.3%
3yr Revenue CAGR
10.5%
EPS Growth YoY
242.86%
FCF Growth YoY
-75.3%
Revenue Trend
STRONG
Dark Pool Trades for SRTA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SRTA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:27 | $6.01 | 1,498 | $$9K | BUY |
| 21:00:27 | $6.01 | 1,392 | $$8K | BUY |
| 21:00:01 | $6.01 | 1,597 | $$10K | SELL |
| 20:58:38 | $5.99 | 1,500 | $$9K | MIDPOINT |
| 20:56:56 | $5.99 | 1,031 | $$6K | MIDPOINT |
5 dark pool trades shown · $$42K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SRTA
PREVIEWSEPT Investing provides real-time options flow tracking for SRTA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $7.5 | Feb 19 | 100 | $$315 | 9 | SWEEP |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Strata Critical Medical, Inc. (SRTA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SRTA — frequently asked questions
What is SRTA stock price today?
Strata Critical Medical, Inc. (SRTA) is at $6.01, down 0.17% (-$0.01) at the Nov 11, 2026 close.
Why is SRTA stock moving today?
Latest SRTA news — Nov 3, 2026: Strata Critical Medical reports third quarter 2026 results · Nov 3, 2026: Strata Critical Medical holds Q3 2026 earnings call
What do analysts rate SRTA?
Analyst ratings for SRTA: 4 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did SRTA beat earnings?
SRTA last reported on Aug 4, 2026: EPS -$0.12 vs -$0.02 expected — a miss of 500.0%.
What is SRTA's P/E ratio?
SRTA trades at a P/E of 8.5 vs a Industrials average of 17.6.
Does SRTA pay a dividend?
SRTA does not currently pay a dividend.
What are SRTA support and resistance levels?
Support: $5.97, $5.52, $5.18. Resistance: $6.33, $6.86, $7.38.
What are insiders doing with SRTA?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on SRTA?
Nov 3, 2026: Strata Critical Medical reports third quarter 2026 results · Nov 3, 2026: Strata Critical Medical holds Q3 2026 earnings call · Nov 3, 2026: Strata Critical Medical posts wider quarterly loss, revenue tops forecast